Express Diagnostics Int’l, Inc. (EDI), manufactures and distributes DrugCheck® onsite urine and saliva screening devices for the detection of drugs of abuse, as well as a growing line of rapid alcohol screening and health diagnostics devices. With accuracy comparable to laboratory testing, Express Diagnostics Int'l onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services.
As an ISO 13485:2003-certified and FDA-registered manufacturer, EDI also offers complete OEM services for private label device manufacturing. Comprehensive in-house marketing, design, and short-run production capabilities speed the private-label development process and reduce costs for distributors.
Founded in 2004 with five employees, Express Diagnostics Int'l is based in Blue Earth, Minn., and has distribution partners in more than 60 countries. EDI also has company representatives in California, Colorado, Massachusetts, and Sofia, Bulgaria.
EDI was honored to be named to the 2013, 2014, and 2015 Inc. 5000 lists of fastest-growing companies in the U.S.A.
Express Diagnostics Global, Ltd. (EDG) was formed in March 2015 as a subsidiary of EDI to service a growing customer base for drugs of abuse screening devices in the EMEA region (Europe, Middle East, and Africa). The planned additional production capacity and EU-based customer service available through EDG, based in Sofia, Bulgaria, offers several advantages, including shorter product lead times for all EDI customers, and faster, lower-cost shipping to EMEA customers. Manufacturing in Bulgaria is scheduled to begin in January 2016.
DrugCheck devices are made in the U.S.A. Sold through a worldwide distributor network since 2002, DrugCheck continues to build on its consistent growth in IVD point-of-care testing. Learn more at drugcheck.com.